NEW SurModics Serene™ low particulate, low friction coatings
Introducing SurModics Serene™ lubricious coatings
for endovascular medical devices.
With growing regulatory awareness of particulate
generation, Serene coatings are a breakthrough technology
that delivers lubricity and durability while significantly
reducing particulates. Serene coatings have been
successfully optimized for a wide range of medical devices
and substrates. They’re also backed by SurModics’
outstanding quality, service and support. Coat your
devices with confidence—SurModics Serene coatings.
952-500-7000 | www.surmodics.com/serene-coatings
cal, which are customizable for the physician,
based on each patient’s anatomical map and
need. Medtronic and Endologix are currently
seeking to bring their more affordable and universally efficient off-the-shelf fenestrated stent
grafts to the U.S. market.
In the quest for the most minimally invasive
procedures, the treatment of aortic valve
disease is often sought through endovascular
methods, such as those used in transcatheter
aortic valve replacement (TAVR). However, as
with many new medical products, the introduction and approval of novel devices into the
U.S. market is a challenging and oftentimes
lengthy one. “The success of TAVR is leading
the way for increased research and development for treating heart valve disorders percu-taenously, with each of the other three valves,
pulmonary, tricuspid and mitral, each having
been successfully treated endovascularly,” says
Transcatheter valves traditionally were
constructed of metal or tissue-based materials,
but these implants require invasive procedures.
For elderly patients, these high-risk procedures
are not an option. Implantable transcathater
valves currently being developed are aimed at
reducing procedural risks. Successful products
seeing significant popularity growth include
the Sapien valve by Edwards Lifesciences, and
the CoreValve by Medtronic.
The most cutting-edge, novel cardiovascular
devices worth further noting are still in the
pre-marketing and development stages. The
industry’s outlook is an exciting one right now,
with several projects in the works. Many of
these products are on the cusp of a new level
of never-before seen advancement, proving
that in the world of cardiovascular, the best is
yet to come.
Following the trends
of the more recent
“disappearing stents,” or
scaffolds, were created.